Literature DB >> 29998024

Uncovering the barriers to undergoing screening among first degree relatives of colorectal cancer patients: a review of qualitative literature.

Ker-Kan Tan1,2,3, Violeta Lopez4, Mee-Lian Wong3, Gerald Choon-Huat Koh3.   

Abstract

First degree relatives (FDRs) of colorectal cancer (CRC) patients are at higher risks of developing the disease, but screening rates amongst this group remains dismal. We undertook a systematic review of qualitative studies to identify the barriers surrounding CRC screening among FDRs from both the FDRs' and the healthcare professionals' perspectives. A comprehensive search of major bibliographic databases from January 2000 till February 2017 was performed to answer the above research questions. Pre-determined inclusion and exclusion criteria were applied. Thematic analysis was used to derive the commonalities across the studies. COREQ checklist was used to evaluate the quality of the included studies. Eight qualitative studies were included. Some of the barriers reported by FDRs included the fear of diagnosis of cancer and socio-cultural barriers. The most important barrier was the FDRs' negative perceptions towards screening test such as discomfort, embarrassment, cost of procedure and accessibility to healthcare resources. Likewise, the lack of awareness amongst FDRs that they are at increased risk of developing CRC was also found to be a barrier. On the other hand, healthcare providers are keen for patients themselves to be advocates for CRC screening of their family members as constraints posed by their daily workload impede their time to advocate screening. Lack of knowledge of the physicians on CRC screening guidelines is another notable barrier. A lack of awareness of being at higher risk of developing CRC coupled with negative attitude towards colonoscopy are the main barriers faced by the FDRs of CRC patients. Healthcare providers are more comfortable with patients being the advocates of screening among their family members.

Entities:  

Keywords:  Colorectal cancer (CRC); barriers; first degree relatives (FDRs); screening

Year:  2018        PMID: 29998024      PMCID: PMC6006027          DOI: 10.21037/jgo.2018.03.02

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  40 in total

Review 1.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

3.  Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme.

Authors:  Merryn Ekberg; Matthew Callender; Holly Hamer; Stephen Rogers
Journal:  Eur J Cancer Prev       Date:  2014-09       Impact factor: 2.497

4.  Improving access to cancer guidelines: feedback from health care professionals.

Authors:  I S Sahota; X Kostaras; N A Hagen
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

5.  African Americans with a family history of colorectal cancer: barriers and facilitators to screening.

Authors:  Kathleen A Griffith; Susan R Passmore; Domanic Smith; Jennifer Wenzel
Journal:  Oncol Nurs Forum       Date:  2012-05-01       Impact factor: 2.172

Review 6.  Screening of colorectal cancer.

Authors:  Sidney J Winawer
Journal:  Surg Oncol Clin N Am       Date:  2005-10       Impact factor: 3.495

7.  Scoping studies: advancing the methodology.

Authors:  Danielle Levac; Heather Colquhoun; Kelly K O'Brien
Journal:  Implement Sci       Date:  2010-09-20       Impact factor: 7.327

8.  Reasons given by relatives of colorectal cancer patients for not undergoing screening.

Authors:  Lisa Madlensky; Mary Jane Esplen; Vivek Goel
Journal:  Prev Med       Date:  2004-10       Impact factor: 4.018

9.  Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.

Authors:  Priscilla Sassoli de Bianchi; Cinzia Campari; Silvia Mancini; Orietta Giuliani; Patrizia Landi; Luisa Paterlini; Carlo Naldoni; Alba C Finarelli; Fabio Falcini; Maurizio Ponz de Leon; Romano Sassatelli; Elisabetta Borciani; Fabio Fornari; Giorgio Gatti; Marella Zatelli; Corrado Zurlini; Federica Rossi; Rossella Corradini; Rossella Olivetti; Marilena Manfredi; Paola Baldazzi; Roberto Nannini; Stefano Zanarini; Vincenzo G Matarese; Caterina Palmonari; Omero Triossi; Sonia Gordini; Rosa Vattiato; Americo Colamartini; Mauro Palazzi; Mirna Severi; Laura Briganti; Mauro Giovanardi; Coralba Casale; Lauro Bucchi
Journal:  Cancer Epidemiol       Date:  2013-05-14       Impact factor: 2.984

10.  Screening behaviors, health beliefs, and related factors of first-degree relatives of colorectal cancer patients with ongoing treatment in Turkey.

Authors:  Serife Koc; Melek Nihal Esin
Journal:  Cancer Nurs       Date:  2014 Nov-Dec       Impact factor: 2.592

View more
  10 in total

1.  The Effects of Health Disparities on Perceptions About Lung Cancer Screening (LCS): Survey Results of a Patient Sample.

Authors:  Sarah Ellen Stephens; Kristie Long Foley; David Miller; Christina R Bellinger
Journal:  Lung       Date:  2019-11-08       Impact factor: 2.584

2.  Familial colonoscopic screening: how do French general practitioners deal with patients and their high-risk relatives. A qualitative study.

Authors:  Isabelle Ingrand; Nicolas Palierne; Pauline Sarrazin; Yvan Desbordes; Clara Blanchard; Pierre Ingrand
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

Review 3.  Patient-Reported Experience Measures for Colonoscopy: A Systematic Review and Meta-Ethnography.

Authors:  Annica Rosvall; Magdalena Annersten Gershater; Christine Kumlien; Ervin Toth; Malin Axelsson
Journal:  Diagnostics (Basel)       Date:  2022-01-19

4.  Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study.

Authors:  Kaitlin M McGarragle; Crystal Hare; Spring Holter; Dorian Anglin Facey; Kelly McShane; Steven Gallinger; Tae L Hart
Journal:  Hered Cancer Clin Pract       Date:  2019-06-26       Impact factor: 2.857

5.  Psychological distance: a qualitative study of screening barriers among first-degree relatives of colorectal cancer patients.

Authors:  Xueying Zhang; Yiheng Zhang; Jingyu Chen; Meifen Zhang; Ni Gong
Journal:  BMC Public Health       Date:  2021-04-13       Impact factor: 3.295

6.  Cancer Screening Knowledge and Behavior in a Multi-Ethnic Asian Population: The Singapore Community Health Study.

Authors:  Tyson Kin-Chung Chan; Linda Wei Lin Tan; Rob M van Dam; Wei Jie Seow
Journal:  Front Oncol       Date:  2021-08-12       Impact factor: 6.244

Review 7.  A risk scoring system to predict the individual incidence of early-onset colorectal cancer.

Authors:  Jialin Gu; Yan Li; Jialin Yu; Miao Hu; Yi Ji; Lingchang Li; Canhong Hu; Guoli Wei; Jiege Huo
Journal:  BMC Cancer       Date:  2022-01-29       Impact factor: 4.430

8.  Motivational Interviewing to Improve the Uptake of Colorectal Cancer Screening: A Systematic Review and Meta-Analysis.

Authors:  Novia Niannian Long; Michele Petrova Xin Ling Lau; Ainsley Ryan Yan Bin Lee; Natalie Elizabeth Yam; Nicholas Ye Kai Koh; Cyrus Su Hui Ho
Journal:  Front Med (Lausanne)       Date:  2022-04-26

9.  Cancer Burden in China during 1990-2019: Analysis of the Global Burden of Disease.

Authors:  Shu-Zhen Zhang; Li Zhang; Long Xie
Journal:  Biomed Res Int       Date:  2022-04-14       Impact factor: 3.246

10.  Smartphone education improves embarrassment, bowel preparation, and satisfaction with care in patients receiving colonoscopy: A randomized controlled trail.

Authors:  Ming-Chu Wen; Kevin Kau; Sheng-Shiung Huang; Wen-Hsin Huang; Li-Yun Tsai; Tsung-Yu Tsai; Shiow-Luan Tsay
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.